Search Results - john+kappler

3 Results Sort By:
Novel Insulin B Chain Peptide to Prevent and Treat Type I Diabetes
Researchers at the University of Colorado have developed a mimotope of insulin B chain amino acids 9-23 (B:9-23) which shows a 100-fold better binding to the HLA-DQ8 molecule and allows for binding in a register that activates CD4 T cells in the nonobese mouse model of spontaneous autoimmune diabetes and human peripheral blood. This allows for the ability...
Published: 11/29/2023   |   Inventor(s): Aaron Michels, George Eisenbarth (Deceased), John Kappler, Peter Gottlieb
Disease Areas Endocrine/Metabolism
Category(s): Therapeutics
Mouse M12.C3 B cell lines that express insulin residues linked to the mouse MHC class II molecule I-AG7
A CU scientist developed two mouse cell lines that expresses variants of the insulin B-chain residues linked to the mouse MHC class II molecules of beta and alpha I-AG7. These cell lines are derivatives of the mouse M12.C3 B cell line, which was originally derived from Balb/c mice that are negative for MHC class II molecules. The first cell line, called...
Published: 5/22/2023   |   Inventor(s): Tomasz Sosinowski, John Kappler
Disease Areas Immunology, Oncology
Category(s): Research Tools
Vaccine for Prevention and Treatment of Autoimmune Diseases
A research team led by Dr. George Eisenbarth has identified and tested a novel antigen-specific strategy for the prevention or treatment of autoimmune diseases. In this new approach, a compound (consisting of a natural immune-system molecule tethered to an autoantigenic peptide that is implicated in the development of a particular autoimmune disease)...
Published: 11/29/2023   |   Inventor(s): Li Zhang, John Kappler, Brian Stadinski, George Eisenbarth (Deceased)
Disease Areas Immunology
Category(s): Therapeutics
For inquiries, email:     © 2024. All Rights Reserved. Powered by Inteum